Marlene and Paolo Fresco Institute for Parkinson’s and Movement Disorders

About the Fresco Institute

The Marlene and Paolo Fresco Institute for Parkinson’s and Movement Disorders at NYU Langone is dedicated to advancing the understanding of, treatment for, and education underlying Parkinson's disease and movement disorders—with the ultimate goal of preventing and curing these diseases. Established in 2015 thanks to a generous $25 million contribution from Marlene and Paolo Fresco, the Fresco Institute is jointly led by the Department of Neurology and the Neuroscience Institute, with Dr. Alessandro Di Rocco, MD, as the inaugural Executive Director and Dr. Richard Tsien, DPhil, as the inaugural Scientific Director. The Fresco Institute also involves scientific and clinical collaboration between the United States and Italy, coordinated through the Fresco Institute-Italia.

The Fresco Institute is building a robust and international suite of clinical, educational, and research programs servicing patients diagnosed with Parkinson’s disease and movement disorders. It is also critical for the next generation of care providers and scientists to gain experience with the most innovative care models, improve upon them, and expand them to as many patients as possible. A critical component of the Fresco Institute therefore is the establishment of clinical and basic research fellowships geared toward addressing gaps in our understanding, treatment, and care of Parkinson’s and movement disorders.

The Fresco Institute’s goals include:

  • advancing groundbreaking research in the field of Parkinson's disease and movement disorders in both clinical and basic science
  • pursuing new treatments that can affect the course of the disease and eventually contribute to finding a cure
  • creating new opportunities for early-career scientists and researchers in Italy through an innovative fellowship program
  • fostering new and lasting programmatic collaborations and shared projects supporting Parkinson's and movement disorders in the United States and Italy, through the engagement of key institutions and foundations
  • creating and establishing an outstanding new medical, research, and educational center in Italy that acts as a centralized hub, coordinating efforts with collaborators in Italy to support improved care, treatment, and ultimately the cure for Parkinson’s and movement disorders
  • strengthening existing patient-centered and family-centered programs and models of care at NYU Langone that embrace medical, rehabilitative, psychological, psychosocial, and supportive care, and develop and transfer replicable programs to Italy.